---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-106238"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:44:19.574058+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma extends equity line with White Lion to Dec 2025, adds rapid share purchase mechanism

## Summary
- Amendment extends existing up-to-$50M stock purchase agreement from Dec 30, 2024 to Dec 30, 2025.
- New 'Rapid Purchase' mechanism allows expedited share sales at lowest traded price on notice date.
- Rapid purchase limit is the lesser of 20% of average daily trading volume or investment limit divided by highest close over five days.
- Standard purchase discount remains 97% (up to $25M) then 98%; rapid purchases use lowest traded price (0% discount).
- Company delivers Rapid Purchase Notice by 11:00 a.m. NY time with concurrent DWAC transfer; payment due next business day by 5 p.m.

## SEC filing metadata
- accession: 0001213900-24-106238
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/0001213900-24-106238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/ea0223902-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-106238
- JSON: https://secwatch.observer/filing/0001213900-24-106238.json
- Plain text: https://secwatch.observer/filing/0001213900-24-106238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.